Frontiers in Oncology (Dec 2022)
Corrigendum: Vestibular schwannoma associated with neurofibromatosis type 2: Clinical course following stereotactic radiosurgery
- Junhyung Kim,
- Yukyeng Byeon,
- Sang Woo Song,
- Young Hyun Cho,
- Chang-Ki Hong,
- Seok Ho Hong,
- Jeong Hoon Kim,
- Do Heui Lee,
- Ji Eun Park,
- Ho Sung Kim,
- Young-Hoon Kim
Affiliations
- Junhyung Kim
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Yukyeng Byeon
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Sang Woo Song
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Young Hyun Cho
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Chang-Ki Hong
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Seok Ho Hong
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Jeong Hoon Kim
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Do Heui Lee
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Ji Eun Park
- Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Ho Sung Kim
- Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Young-Hoon Kim
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- DOI
- https://doi.org/10.3389/fonc.2022.1100854
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
- neurofibromatosis type 2 (NF2)
- vestibular schwannoma (acoustic neuroma)
- stereotactic radiosurgery (SRS)
- tumor control
- hearing preservation